Micrus Delays Launch Of Steerable Catheter; Microcatheter Still On Track
This article was originally published in The Gray Sheet
Executive Summary
Micrus Endovascular pushed back the projected launch date of its steerable neuro/endovascular catheter in order to strengthen its 510(k) submission
You may also be interested in...
Micrus IPO To Fund Japan Aneurysm Coil Market Entry, Bioactive Coil R&D
Micrus will establish a Japanese distribution network later this year with proceeds from an initial public offering of up to $57.5 mil. in common stock
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.